Clinical Pharmacist Intervention to Reduce Drug-related Readmissions Among Older People
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Enhanced clinical pharmacist service.
- Кому может быть актуально
- Состояния в реестре: Drug Use. Базовые параметры: от 75 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Швеция
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
Involving Clinical Pharmacists in Transitional Care to Reduce Drug-related Readmissions Among the Elderly - a Randomized Controlled Trial
Обзор
This randomized controlled trial primarily investigates if a clinical pharmacist intervention can reduce drug-related readmissions among patients \>75 years. The intervention targets the transfer between hospital and primary care. In brief, the intervention includes medical chart reviews and patient interviews during a period of 180 days.
Подробное описание
At discharge from the hospital, patients that meet the inclusion criteria are offered to participate in the study. At this point the investigators will also gather baseline data through questionnaires on self-reported adherence (MARS-5) and quality of life (EQ-5D). The participants are randomized to the different study arms according to a stratified procedure based on their cognitive function.
The intervention group will have their charts reviewed every second week and be contacted by the clinical pharmacist through phone within 7 and after 30 and 60 days respectively to discuss their medications. If possible drug-related problems are suspected during the interviews that cannot be solved immediately, the physician is contacted.
Both groups have a follow-up time of 30 and 180 days. After 30 and 180 days, the patients will once again report adherence and quality of life. All other data can be gathered from the medical charts.
Вмешательства
- Другое Enhanced clinical pharmacist service
The intervention includes regular medical chart reviews, multiple patient interviews and, if needed, collaboration with the primary care physician.
Первичные конечные точки
- Time from discharge to first drug-related readmission [Срок оценки: 180 days]
Вторичные конечные точки (12)
- Time from discharge to first drug-related readmission [Срок оценки: 30 days]
- Frequency of drug-related readmissions [Срок оценки: 30 and 180 days]
- Time from discharge to first drug-related readmission - subgroups with/without heart failure [Срок оценки: 30 and 180 days]
- Time from discharge to first drug-related readmission - subgroups with/without cognitive impairment [Срок оценки: 30 and 180 days]
- Frequency of drug-related readmissions - subgroups with/without cognitive impairment [Срок оценки: 30 and 180 days]
- Frequency of drug-related readmissions - subgroups with/without heart failure [Срок оценки: 30 and 180 days]
- Time from discharge to first all-cause hospital visit [Срок оценки: 30 and 180 days]
- Frequency of all-cause hospital visits [Срок оценки: 30 and 180 days]
- Self-reported adherence [Срок оценки: 30 and 180 days]
- Self assessed quality of life: EQ-5D-questionnaire [Срок оценки: 30 and 180 days]
- Health economics [Срок оценки: 180 days]
- Medication appropriateness [Срок оценки: 180 days]
Критерии участия
Критерии включения
- Living at home
- Acutely admitted
- Registered at one of ten pre-specified primary care health centers
Критерии исключения
- Patients unable to communicate or who do not speak Swedish
- Patients scheduled for palliative care
- Patients admitted due to intoxication by alcohol or drug (non prescription)
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Да
Дизайн исследования
- Распределение
- Рандомизированное
- Модель
- Параллельные группы
- Маскирование
- Простое слепое
- Основная цель
- Другое
Центры проведения
Швеция · 1 центр
- Medical Centre, University Hospital of Umeå — Umeå
Публикации
- Kindstedt J, Svahn S, Sjolander M, Glader EL, Lovheim H, Gustafsson M. Investigating the effect of clinical pharmacist intervention in transitions of care on drug-related hospital readmissions among the elderly: study protocol for a randomised controlled trial. BMJ Open. 2020 Apr 27;10(4):e036650. doi: 10.1136/bmjopen-2019-036650. PMID 32345700
Идентификаторы
NCT: NCT03671629 · UmU-2018-700